For semaglutide specifically, patients with kidney dysfunction do not require renal dosing adjustments (Key Considerations in Use of SGLT2 Inhibitors and GLP-1RAs for CV Risk Reduction in Patients with T2D, 2020) Contraindications to GLP-1 agonists include a history of serious hypersensitivity reactions to a GLP-1 agonist, pregnancy, breastfeeding, and a personal or family history of medullary or thyroid cancer or MEN2 (Key Considerations in Use of SGLT2 Inhibitors and GLP-1RAs for CV Risk Reduction in Patients with T2D, 2020)
Preparing for your first semaglutide shot involves not just understanding the practical steps, but also nurturing your emotional well-being
Its not that Im against the medications, said Dr
This is why 0.25mg is the evidence-based starting point, not 1mg
Based on some recent media reports, it seems peptides such as retatrutide may affect more than just appetite